Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-Optimization Study for the Initial Treatment of Dysplastic Barrett's Esophagus With trūFreeze™ Spray Cryotherapy ("DOSE" Trial)

NCT01845454 is registered in ClinicalTrials.gov with CSA Medical, Inc. as lead sponsor.

NCT NCT01845454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01845454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-Optimization Study for the Initial Treatment of Dysplastic Barrett's Esophagus With trūFreeze™ Spray Cryotherapy ("DOSE" Trial)
Lead sponsor
CSA Medical, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
April 30, 2013
Completion date
January 31, 2015
Enrollment
36 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

barrett's esophagus